McDonald Capital Investors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $120M | Sell |
193,038
-12,833
| -6% | -$8.74M | 8.79% | 3 |
|
|
2026
Q1 | $159M | Sell |
205,871
-2,370
| -1% | -$1.81M | 10.89% | 2 |
|
|
2025
Q4 | $161M | Sell |
208,241
-5,090
| -2% | -$3.46M | 9.86% | 2 |
|
|
2025
Q3 | $120M | Sell |
213,331
-4,714
| -2% | -$2.67M | 7.46% | 5 |
|
|
2025
Q2 | $114M | Buy |
218,045
+21,272
| +11% | +$11.9M | 7.18% | 7 |
|
|
2025
Q1 | $125M | Buy |
196,773
+26,593
| +16% | +$18.3M | 7.87% | 4 |
|
|
2024
Q4 | $121M | Buy |
170,180
+33,727
| +25% | +$28.3M | 7.61% | 6 |
|
|
2024
Q3 | $143M | Sell |
136,453
-2,746
| -2% | -$3.06M | 8.8% | 4 |
|
|
2024
Q2 | $146M | Sell |
139,199
-1,814
| -1% | -$1.76M | 9.14% | 3 |
|
|
2024
Q1 | $136M | Sell |
141,013
-2,516
| -2% | -$2.39M | 8.5% | 3 |
|
|
2023
Q4 | $126M | Sell |
143,529
-2,590
| -2% | -$2.13M | 8.79% | 3 |
|
|
2023
Q3 | $120M | Sell |
146,119
-3,080
| -2% | -$2.42M | 9.38% | 3 |
|
|
2023
Q2 | $107M | Sell |
149,199
-3,265
| -2% | -$2.52M | 8% | 4 |
|
|
2023
Q1 | $125M | Sell |
152,464
-4,122
| -3% | -$3.11M | 9.55% | 2 |
|
|
2022
Q4 | $113M | Sell |
156,586
-4,385
| -3% | -$3.24M | 9.39% | 4 |
|
|
2022
Q3 | $111M | Sell |
160,971
-3,111
| -2% | -$1.96M | 9.85% | 3 |
|
|
2022
Q2 | $97M | Sell |
164,082
-1,531
| -0.9% | -$995K | 8.1% | 4 |
|
|
2022
Q1 | $116M | Sell |
165,613
-540
| -0.3% | -$342K | 8.25% | 4 |
|
|
2021
Q4 | $105M | Sell |
166,153
-1,675
| -1% | -$1.03M | 7.36% | 5 |
|
|
2021
Q3 | $102M | Sell |
167,828
-6,610
| -4% | -$4.1M | 7.87% | 4 |
|
|
2021
Q2 | $97.4M | Sell |
174,438
-3,368
| -2% | -$1.71M | 7.32% | 5 |
|
|
2021
Q1 | $84.1M | Sell |
177,806
-365
| -0.2% | -$178K | 6.71% | 9 |
|
|
2020
Q4 | $86.1M | Sell |
178,171
-1,768
| -1% | -$954K | 7.16% | 7 |
|
|
2020
Q3 | $101M | Sell |
179,939
-1,359
| -0.7% | -$824K | 8.98% | 3 |
|
|
2020
Q2 | $113M | Sell |
181,298
-10,270
| -5% | -$5.83M | 10.61% | 2 |
|
|
2020
Q1 | $93.5M | Sell |
191,568
-4,295
| -2% | -$1.77M | 9.1% | 4 |
|
|
2019
Q4 | $73.5M | Sell |
195,863
-13,817
| -7% | -$4.65M | 6.26% | 11 |
|
|
2019
Q3 | $58.2M | Buy |
209,680
+16,680
| +9% | +$4.94M | 4.92% | 11 |
|
|
2019
Q2 | $60.4M | Buy |
193,000
+58,015
| +43% | +$19.3M | 4.92% | 11 |
|
|
2019
Q1 | $55.4M | Sell |
134,985
-5,435
| -4% | -$2.24M | 4.6% | 11 |
|
|
2018
Q4 | $52.4M | Buy |
140,420
+35,885
| +34% | +$13.1M | 4.91% | 11 |
|
|
2018
Q3 | $42.2M | Buy |
104,535
+94,035
| +896% | +$35.8M | 3.5% | 11 |
|
|
2018
Q2 | $3.62M | Buy |
+10,500
| New | +$3.28M | 0.29% | 15 |
|
Other funds holding REGN
McDonald Capital Investors's REGN Position: Q2 2026 in Review
McDonald Capital Investors reduced its Regeneron Pharmaceuticals (REGN) stake by 6.2% in Q2 2026, selling an estimated $8.74M and leaving 193,038 shares worth $120M. The position accounts for 8.79% of the portfolio, ranked #3.
McDonald Capital Investors first reported a position in REGN in Q2 2018 and has held it in 33 quarters since. The position peaked at $161M in Q4 2025. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- McDonald Capital Investors held 193,038 shares of Regeneron Pharmaceuticals worth $120M as of Q2 2026.
- McDonald Capital Investors sold 12,833 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $8.74M.
- Regeneron Pharmaceuticals made up 8.79% of McDonald Capital Investors's portfolio in Q2 2026, its #3 holding.
- McDonald Capital Investors first reported a position in Regeneron Pharmaceuticals in Q2 2018 and has held it in 33 quarters since.
- McDonald Capital Investors's Regeneron Pharmaceuticals position peaked at $161M in Q4 2025.
- 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on McDonald Capital Investors's 13F filing for Q2 2026, filed 29 Jul 2026.